MAPT and Alzheimer disease: AD causes persistent cognitive impairment and is clinically associated with elevated levels of acetylcholinesterase inhibitors (AChE), β-amyloid 1-42 (Aβ1-42), phospho-Tau protein (p-Tau), and Tau protein.